Cargando…
Enhanced Mucosal Antibody Production and Protection against Respiratory Infections Following an Orally Administered Bacterial Extract
Secondary bacterial infections following influenza infection are a pressing problem facing respiratory medicine. Although antibiotic treatment has been highly successful over recent decades, fatalities due to secondary bacterial infections remain one of the leading causes of death associated with in...
Autores principales: | Pasquali, Christian, Salami, Olawale, Taneja, Manisha, Gollwitzer, Eva S., Trompette, Aurelien, Pattaroni, Céline, Yadava, Koshika, Bauer, Jacques, Marsland, Benjamin J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4292070/ https://www.ncbi.nlm.nih.gov/pubmed/25593914 http://dx.doi.org/10.3389/fmed.2014.00041 |
Ejemplares similares
-
Targeting IL-1β and IL-17A Driven Inflammation during Influenza-Induced Exacerbations of Chronic Lung Inflammation
por: Sichelstiel, Anke, et al.
Publicado: (2014) -
Has the airway microbiome been overlooked in respiratory disease?
por: Salami, Olawale, et al.
Publicado: (2015) -
Use of Biopolymers in Mucosally-Administered Vaccinations for Respiratory Disease
por: Dedloff, Margaret R., et al.
Publicado: (2019) -
Sperm Microbiota and Its Impact on Semen Parameters
por: Baud, David, et al.
Publicado: (2019) -
Butyrate regulates neutrophil homeostasis and impairs early antimicrobial activity in the lung
por: Dang, Anh Thu, et al.
Publicado: (2023)